Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending ...

Hims & Hers has been an incredible stock to own over the last few years, making shareholders rich. It has $2 billion in ...

Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and the risks ...

The healthcare company is experiencing excellent sales growth, but investors are concerned about its longer-term prospects.

At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more ...

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

Aug 5 - Hims & Hers Health shares took a hit on Tuesday, dropping more than 10% in early trading. The telehealth company ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

The telehealth-consultation platform posted an increase in profit and revenue for the second quarter on growth in subscribers ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...